NICE

News

Price cut leads NICE to back Novo Nordisk’s obesity drug Sax...

Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management.

Views & Analysis

NICE talking to you: Trends in early HTA engagement

With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look at the trend in early engagemen

News

NICE changes stance on Keytruda for first-line head and neck...

As recently as June, NICE was minded not to back routine NHS of MSD’s Keytruda as a first-line treatment for advanced head and n

News

Illustration of a nerve cell on a colored background with light effects

Lilly to buy private biotech Disarm Therapeutics for up to $...

Eli Lilly is to buy the private biotech Disarm Therapeutics, which is working on a new class of disease-modifying drugs for neurological diseases, in a deal worth up to $1.36 billion.

News

NICE changes its mind on Novartis’ progressive MS drug Mayze...

UK cost-effectiveness agency NICE has backed Novartis’ Mayzent for secondary progressive multiple sclerosis (SPMS), after turning it down earlier this year in draft guidance.

News

Scotland backs two myeloma drugs turned down by NICE in Engl...

A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines Consortium (SMC) backed NHS use of two drugs previously turned down by NICE in England.<

Price cut leads NICE to back Novo Nordisk’s obesity drug Sax...

NICE talking to you: Trends in early HTA engagement

NICE changes stance on Keytruda for first-line head and neck...

Lilly to buy private biotech Disarm Therapeutics for up to $...

NICE changes its mind on Novartis’ progressive MS drug Mayze...

Scotland backs two myeloma drugs turned down by NICE in Engl...

Hengrui gets world-first okay for platelet drug hetrombopag

Discover a new era of healthcare panel engagement: Grounded ...

NICE

Editor's Picks